John M. Pietruski
Directeur/Membre du Conseil chez Xylos Corp.
Profil
John M.
Pietruski is currently a Director at Xylos Corp.
He was previously the Chairman & CEO at Sterling Drug, Inc. from 1977 to 1988, and the Chairman at Encysive Pharmaceuticals, Inc. from 1990 to 2008.
He also served as a Director at Interpace Biosciences, Inc. from 1998 to 2010 and is currently a Director at FirstEnergy Corp.
Mr. Pietruski received his undergraduate degree from Rutgers State University of New Jersey in 1954.
Postes actifs de John M. Pietruski
| Sociétés | Poste | Début |
|---|---|---|
Xylos Corp.
 Xylos Corp. BiotechnologyHealth Technology Xylos Corp. provides biotechnology solutions. The firm operates as a medical device company that offers superior biomaterial solutions for the treatment, repair and replacement of human tissue. The company was founded by Gonzalo C. Serafica in 1996 and is headquartered in Newtown, PA. | Directeur/Membre du Conseil | 01/12/2001 |
Anciens postes connus de John M. Pietruski
| Sociétés | Poste | Fin |
|---|---|---|
| INTERPACE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/05/2010 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Président | 01/04/2008 |
| Sterling Drug, Inc. | Président | 01/01/1988 |
Mercalis, Inc.
 Mercalis, Inc. Information Technology ServicesTechnology Services TrialCard, Inc. provides customer related solutions to pharma industry. It offers analytics, customer experience management, patient affordability, pharmacy, product access support and tailored services which include adherence measures, business intelligence case management and navigation services. The company was founded by David Cunningham in 2000 and is headquartered in Morrisville, NC. | Directeur/Membre du Conseil | - |
| FIRSTENERGY CORP. | Directeur/Membre du Conseil | - |
Formation de John M. Pietruski
| Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FIRSTENERGY CORP. | Utilities |
| INTERPACE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Mercalis, Inc.
Mercalis, Inc. Information Technology ServicesTechnology Services TrialCard, Inc. provides customer related solutions to pharma industry. It offers analytics, customer experience management, patient affordability, pharmacy, product access support and tailored services which include adherence measures, business intelligence case management and navigation services. The company was founded by David Cunningham in 2000 and is headquartered in Morrisville, NC. | Technology Services |
Xylos Corp.
Xylos Corp. BiotechnologyHealth Technology Xylos Corp. provides biotechnology solutions. The firm operates as a medical device company that offers superior biomaterial solutions for the treatment, repair and replacement of human tissue. The company was founded by Gonzalo C. Serafica in 1996 and is headquartered in Newtown, PA. | Health Technology |
| Sterling Drug, Inc. | Consumer Non-Durables |
